Market supply obligations

With the publication in Infarmed’s website of the Drug Availability Management Regulation approved by Infarmed’s board of directors, occurred yesterday, the recent revision of the legal framework of medicinal products supply obligations contained in Decree-Law nr. 112/2019 of 16 August (“Decree-Law 112/2019”) that amended the Medicinal Products Legal Act2 , was completed.